Drugs Made In America Acquisition II market cap DMII
Share price times shares outstanding: what the whole company sells for, since 2025.
- Today, Nov 2, 2026
- $650.4M
- Highest close in our data
- $655.1M
- Feb 2026
Drugs Made In America Acquisition II is worth $650.4M at the close on Nov 2, 2026, at $10.21 a share.
That is up 0% over the last year.
Its highest close in our data was $655.1M in Feb 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $650.4M | $637.6M | $655.1M | +0% |
| 2025 | $649.2M | $647.2M | $650.5M | n/a |
Against its peers
Companies in Financial Services nearest Drugs Made In America Acquisition II's size, closest first, today.
| Company | Market cap |
|---|---|
| DMIIDrugs Made In America Acquisition II | $650.4M |
| PRTHPriority Technology | $652.1M |
| FBIZFirst Business Financial Services | $647.7M |
| CARECarter Bankshares | $642.8M |
| VELVelocity Financial | $637.2M |
| TCBXThird Coast Bancshares | $677.4M |
| GCBCGreene County Bancorp | $623M |
| ACNBAcnb | $682.6M |
| CASSCass Information Systems | $692.7M |
| MSBIMidland States Bancorp | $693.6M |
| BHBBar Harbor Bankshares | $694.6M |
| Peer median | $664.7M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Drugs Made In America Acquisition II
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.